Detalhe da pesquisa
1.
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
Front Oncol
; 12: 1060864, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727071
2.
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.
Cancer Med
; 10(19): 6642-6652, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382365
3.
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.
Eur Urol Oncol
; 3(2): 168-173, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31956080
4.
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy.
Eur Urol Focus
; 6(5): 999-1005, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30738795
5.
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
Eur Urol
; 73(2): 149-152, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28917596
6.
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.
Eur Urol
; 69(3): 450-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364551
7.
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.
JAMA Oncol
; 2(10): 1303-1309, 2016 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27254750
8.
Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer.
Bladder Cancer
; 2(4): 405-413, 2016 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28035321